Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00231296 · ClinicalTrials.gov registry record · NA

Safety and Efficacy of CryoCor™ Cryoablation for PAF

A NA study of Atrial Fibrillation, sponsored by Boston Scientific Corporation.

Completed
Registry status
NA
Development phase
174
Enrollment target
20
Study locations

NCT00231296 is a NA study of Atrial Fibrillation that has completed, run by Boston Scientific Corporation. The registered enrollment target is 174 participants, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (94% lower). The trial reports 20 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00231296, a NA study of Atrial Fibrillation, has completed, sponsored by Boston Scientific Corporation.

COMPLETED
Registry status
NA
Development phase
174 participants
Enrollment target
20
Study locations

Study Summary

A multi-center, randomized, controlled study of cryoablation vs medical management for the treatment of PAF

Conditions Studied

Atrial Fibrillation

Interventions

  • DEVICE Cardiac CryoCor Cryoablation System
  • DRUG Medical management

Study Locations (20)

California

  • Regional Cardiology Associates - Sacramento
  • UCSD Medical Center - San Diego
  • UCSF Medical - San Francisco

Florida

  • University of Florida - Gainesville
  • University of South Florida - Tampa

Illinois

  • University of Chicago Hospitals - Chicago
  • Carle Heart Center - Urbana

Iowa

  • Genesis Health - Davenport
  • Iowa Heart Center - Des Moines

New York

  • St. Luke's-Roosevelt Hospital Center - New York
  • University of Rochester Medical Center - Rochester

Pennsylvania

  • Penn State Heart and Vascular Institute - Hershey
  • Drexel University - Philadelphia

Georgia

  • Emory University - Atlanta

Kentucky

  • Cardiology Associates of Kentucky - Lexington

Trial Details

FieldValue
Enrollment Target 174 participants
Start Date 2004-11
Est. Completion 2009-03
Phase NA

Sponsor

Boston Scientific Corporation

280 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00231296

The ClinicalTrials.gov registry entry for NCT00231296 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 174 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (94% lower). The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 2 interventions - of which Cardiac CryoCor Cryoablation System is the first listed.

NCT00231296 reports 20 study locations spanning 13 distinct geographic areas - top geographies include California, Florida, Illinois.

Frequently Asked Questions

What is clinical trial NCT00231296 about?

NCT00231296 is a clinical study titled "Safety and Efficacy of CryoCor™ Cryoablation for PAF". A multi-center, randomized, controlled study of cryoablation vs medical management for the treatment of PAF

What is the current status of trial NCT00231296?

This trial is currently completed. It is a NA study. The enrollment target is 174 participants. The study started on 2004-11. Estimated completion is 2009-03.

What conditions does trial NCT00231296 study?

This clinical trial studies the following conditions: Atrial Fibrillation.

What interventions are being tested in trial NCT00231296?

The interventions under investigation include: Cardiac CryoCor Cryoablation System (DEVICE), Medical management (DRUG).

Who is sponsoring clinical trial NCT00231296?

This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00231296 being conducted?

This trial has 20 study locations across California, Florida, Georgia, Illinois, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Atrial Fibrillation

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.